SUV39H2 and lung carcinoma: Previous work in our laboratory demonstrated that SUV39H2-mediated H2AX methylation increases the formation of γ-H2AX in lung cancer cells and that inhibition of SUV39H2 enhances chemosensitivity of lung cancer cells to cisplatin or DOX [12].